Elizabeth Fowler

Dr. Fowler is an expert in biotechnology research and development activities with extensive experience in leading teams focused on biopharmaceutical and vaccine projects at various stages ranging from basic academic research through to clinical development, validation and NDA/BLAs. She has quality, analytical and regulatory expertise in biological and chemically synthesized drugs with expertise in implementation of single use equipment in manufacturing operations, including design and quality specifications, supplier qualification, validation, GMP procedures, and training, as well as applying Quality be Design principles to manufacturing and testing of biopharmaceuticals, and planning and executing CMC strategies. She has held positions at Xcellerex, Inc. and Millenium Pharmaceuticals, Inc., Autoimmmune, Inc., and Ciba-Geigy, as well as faculty positions at several universities. Dr. Fowler has a PhD from Harvard University.